NEW

DePuy Synthes Receives 510(k) FDA Clearance for VELYS™ Robotic-Assisted Solution Designed for Use with the ATTUNE Total Knee System

The Johnson & Johnson Medical Devices Companies announced that DePuy Synthes has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VELYS Robotic-Assisted Solution designed for use with the ATTUNE® Total Knee System and its cleared indications for use.

Philips to Acquire Capsule Technologies Inc.

Royal Philips has signed an agreement to acquire Capsule Technologies Inc., a provider of medical device integration and data technologies for hospitals and healthcare organizations.

Camber Spine Expands Patent Portfolio with SPIRA Lateral 3.0

Camber Spine has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for its SPIRA Lateral 3.0 interbody fusion implant.

UVDI-360 Room Sanitizer Inactivates SARS-CoV-2 at 12 Feet Distance in 5 Minutes

UltraViolet Devices Inc. (UVDI) has announced that its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).

Exactech Appoints New Chief Financial Officer

Exactech, a developer and producer of innovative implants, instrumentation and computer-assisted technologies for joint replacement surgery, has announced Kerem Bolukbasi as its new chief financial officer (CFO). Bolukbasi joins Exactech from TPG Capital where he served as an operations executive and was responsible for providing interim executive leadership and operational support to management teams and boards of directors for the firm’s portfolio companies.

“It’s a pleasure to officially welcome Kerem to the Exactech team where he will undoubtedly make a great impact on our success,” said Exactech Chief Executive Officer Darin Johnson. “Kerem has already contributed significantly to supporting our business continuity efforts throughout the COVID-19 pandemic. We look forward to leveraging his experience in leading global financial and operational functions across large and diverse companies to position Exactech for sustainable, long-term growth and enhanced valuation.”

According to Bolukbasi, “Exactech is differentiated in the orthopaedics industry with an exciting and aggressive pipeline of new technologies and solutions for surgeons and patients across the globe. I am thrilled to join the company at this exciting and pivotal time.”

Bolukbasi’s roles with TPG Capital have included interim CFO and COO for Vice Media, Transplace, McAfee, Fleetpride and Adare Pharmaceuticals. Prior to this, he served as CFO for the GE Gas Engines and Engineering Division of GE Energy. Bolukbasi will lead Exactech’s global financial operations, finance teams and activities. He will report directly to Johnson and will succeed Jody Phillips, who has served as Exactech’s CFO for the past 27 years.

“Since joining the company in 1993, Jody has been a respected leader and mentor to many Exactech employees,” Johnson said. “He was instrumental in the company’s growth from the initial public offering in 1996, through our go-private transition with TPG Capital in 2018 and beyond. I’d like to thank Jody both personally and on behalf of Exactech for his dedicated service and contributions.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X